{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:22:00Z","timestamp":1787498520842,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd003633","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2005,1,24]],"date-time":"2005-01-24T00:00:00Z","timestamp":1106524800000}}],"reference-count":49,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003633.pub2","type":"journal-article","created":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T10:50:44Z","timestamp":1106736644000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Botulinum toxin type A therapy for cervical dystonia"],"prefix":"10.1002","author":[{"given":"Jo\u00e3o","family":"Costa","sequence":"first","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia C","family":"Esp\u00edrito-Santo","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana A","family":"Borges","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel M","family":"Coelho","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Moore","sequence":"additional","affiliation":[{"name":"NHS Trust; The Walton Centre for Neurology and Neurosurgery; Lower Lane Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sampaio","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,1,24]]},"reference":[{"key":"10.1002\/14651858.CD003633.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp.53.8.640","article-title":"Botulinum toxin treatment in spasmodic torticollis","volume":"53(8)","author":"Blackie","year":"1990","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0002|cit2","first-page":"S5","article-title":"Botulinus toxin in the treatment of spasmodic torticollis long-term results","author":"Turjanski","year":"1990","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0003|cit3","first-page":"276 (P4.243)","article-title":"A randomized double-blind, placebo-controlled study of intramuscular BOTOX for the treatment of cervical Dystonia (CD)","volume":"13 Suppl 2","author":"Brashear","year":"1998","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0004|cit4","unstructured":"Comella C Botox for Cervical Dystonia Toxins'99 (www.wemove.org) 8"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0005|cit5","first-page":"30","article-title":"A Randomized, Multicenter, Placebo-Controlled Study of Original Botox (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Treatment of Cervical Dystonia","volume":"15 Suppl 2","author":"Hauser","year":"2000","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0006|cit6","first-page":"320","article-title":"Change in Pattern of Muscle Activity Following Botulinum Toxin Injections for Torticollis","volume":"39 Suppl 1","author":"Gelb","year":"1989","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0007|cit7","doi-asserted-by":"crossref","unstructured":"Gelb DJ Lowenstein DH Aminoff MJ Botulinum Toxin in the Treatment of Spasmodic Torticollis Neurology 1988 244","DOI":"10.1212\/WNL.39.1.80"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.39.1.80","article-title":"Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis","volume":"39(1)","author":"Gelb","year":"1989","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0009|cit9","first-page":"244","article-title":"Double-blind, Placebo-controlled Study of Botulinum Toxin Injection for Torticollis","volume":"38 Suppl 1","author":"Greene","year":"1988","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/WNL.40.8.1213","article-title":"Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis","volume":"40(8)","author":"Greene","year":"1990","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002826-199008000-00011","article-title":"Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollis","volume":"13(4)","author":"Koller","year":"1990","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/mds.870060210","article-title":"Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients","volume":"6(2)","author":"Lorentz","year":"1991","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0013|cit13","first-page":"189","article-title":"Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia","volume":"94(4)","author":"Lu","year":"1995","journal-title":"Journal of the Formosan Medical Association"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jnnp.54.9.813","article-title":"A double blind trial of botulinum toxin \"A\" in torticollis, with one year follow up","volume":"54(9)","author":"Moore","year":"1991","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0015|cit15","first-page":"S5","article-title":"Double blind study of botulinum toxin A in torticollis","author":"Moore","year":"1990","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0168-5597(94)90150-3","article-title":"Quantitative EMG in botulinum toxin treatment of cervical dystonia. A double-blind, placebo-controlled study","volume":"93(6)","author":"Ostergaard","year":"1994","journal-title":"Electroencephalography and Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0019|cit17","unstructured":"Poewe W Dysport for Cervical Dystonia Toxins'99 (www.wemove.org) 10"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0017|cit18","unstructured":"Poewe W Brans J Kessler K Kanovsky P Odergren T Aramideh M Dysport for Cervical Dystonia Movement Disorders 2000 7"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0018|cit19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.64.1.13","article-title":"What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group","volume":"64(1)","author":"Poewe","year":"1998","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0020|cit20","first-page":"S306 (P1007)","article-title":"The efficacy and safety of Dysport (botulinum type A toxin) in cervical dystonia: Results of the first US study","volume":"17 Suppl 5","author":"DD","year":"2002","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0021|cit21","first-page":"245","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2;2","author":"Tsui","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0022|cit22","unstructured":"Kanovsky P Ruzicka E Jech R Roth J Schnider P Auff E Standardized dose of 500 Mu of Dysport for Cervical Dystonia: Results of a prospective, randomized, double-blind, placebo-controlled study Movement Disorders 2000 31"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0024|cit23","unstructured":"Poewe W Dysport for Cervical Dystonia Toxins'99 (www.wemove.org) 10"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0023|cit24","unstructured":"Poewe W Brans J Kessler K Kanovsky P Odergren T Aramideh M Dysport for Cervical Dystonia Movement Disorders 2000 7"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s004150170028","article-title":"Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study","volume":"248(12)","author":"Wissel","year":"2001","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003633.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00002826-199404000-00008","article-title":"Determining a Dose-Effect Curve for Botulinum Toxin in the Sternocleidomastoid Muscle in Cervical Dystonia","volume":"17","author":"Buchman","year":"1994","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0028|cit27","first-page":"583","article-title":"Blepharospasm and Oromandibular-Laryngeal Cervical Dystonia: A Controlled Trial of Botulinum A Toxin Therapy","volume-title":"Advances in Neurology","volume":"50: Dystonia 2","author":"Jankovic","year":"1988"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0027|cit28","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mus.880140711","article-title":"Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes","volume":"14","author":"Lange","year":"1991","journal-title":"Muscle and Nerve"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0030|cit30","first-page":"73 (P262)","article-title":"Botulinum Toxin Therapy for Blepharospasm, Hemifacial Spasm and Spasmodic Torticollis: Clinical Studies with a Follow-up of 40 Months","volume":"5 Suppl 1","author":"Maurri","year":"1990","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0031|cit31","first-page":"352","article-title":"Double-blind, Placebo-controlled, Crossover Trial of Botulinum-A Toxin for Torticollis","volume":"39 Suppl 1","author":"Perlmutter","year":"1989","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0032|cit32","first-page":"S185 (6-17-01)","article-title":"Botulinum toxin type A injections for cervical dystonia: a double-blind, placebo controlled study","volume":"20 Suppl 4","author":"Relja","year":"1993","journal-title":"The Canadian Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0033|cit33","first-page":"593","article-title":"Botuinum Toxin in Spasmodic Torticollis","volume-title":"Advances in Neurology","volume":"50: Dystonia 2","author":"Tsui","year":"1988"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0034|cit34","first-page":"75 (P268)","article-title":"Long Term Follow-up of Patients Treated with Botulinum Toxin for Spasmodic Torticollis","volume":"5 (Suppl 1)","author":"Yoshimura","year":"1990","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/bmj.313.7055.486","article-title":"Statistics notes. Interaction 1: Heterogeneity of effects","volume":"313(7055)","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0036|cit36","article-title":"Meta-analysis, Simpson's paradox, and the number needed to treat","volume":"2(1):3. Epub 20","author":"Altman","year":"2002","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0037|cit37","first-page":"275","article-title":"Cervical Dystonia Severity Scale (CDSS) reliability study","volume":"13","author":"Brashear","year":"1998","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/mds.870060206","article-title":"Idiopathic cervical dystonia: clinical characteristics","volume":"6","author":"Chan","year":"1991","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials: the CONSORT statement","volume":"276(8)","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0040|cit40","first-page":"787","article-title":"The Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group","volume":"247","author":"ESDE","year":"2000","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3171\/jns.1959.16.1.0055","article-title":"Experimental spasmodic torticollis","volume":"16","author":"Foltz","year":"1959","journal-title":"Journal of Neurosurgery"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archneur.1990.00530050070014","article-title":"Natural history of adult-onset idiopathic torticollis","volume":"47","author":"Jahanshahi","year":"1990","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1212\/WNL.41.7.1088","article-title":"Cervical dystonia: clinical findings and associated movement disorders","volume":"41","author":"Jankovic","year":"1991","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mds.870030302","article-title":"Epidemiology of focal and generalized dystonia in Rochester, Minnesota","volume":"3(3)","author":"Nutt","year":"1988","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.318.7197.1548","article-title":"Numbers needed to treat derived from meta-analysis - sometimes informative, usually misleading","volume":"318(7197)","author":"Smeeth","year":"1999","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD003633.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.870120117","article-title":"Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin","volume":"12","author":"Tarsy","year":"1997","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0047|cit47","first-page":"211","volume-title":"Clinical assessments of patients with cervical dystonia","author":"Consky","year":"1994"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0048|cit48","first-page":"29","article-title":"Botulinum toxin type A for the treatment of cervical dystonia: a systematic review","volume":"15 Suppl 3","author":"Costa","year":"2000","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub2-BIB0049|cit49","first-page":"76","article-title":"Botulinum toxin type A for the treatment of cervical dystonia: a systematic review","volume":"6 Suppl 3","author":"Ferreira","year":"1999","journal-title":"European Journal of Neurology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003633.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T00:00:00Z","timestamp":1513036800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003633.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T16:07:44Z","timestamp":1682957264000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003633.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Movement Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2005,1,24]]},"references-count":49,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003633.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,24]]}}}